Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
ETFs with UTHR as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|1.36%||Guggenheim S&P Midcap 400 Pure Growth ETF (RFG)||+7.67 (6.64%)|
|0.49%||Vanguard Small-Cap Growth ETF - DNQ (VBK)||+14.58 (13.19%)|
|0.26%||Schwab U.S. Small-Cap ETF (SCHA)||+7.02 (14.70%)|
Company Description (as filed with the SEC)
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening diseases. Our key therapeutic products and product candidates include: º * º Prostacyclin Analogues. Prostacyclin analogues are stable synthetic forms of prostacyclin, an important molecule produced by the body that has powerful effects on blood vessel health and function. Our lead product is Remodulin® (treprostinil) Injection (Remodulin), which is administered subcutaneously (under the skin) or intravenously (in the vein) for the treatment of pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise. ... More ...
Where does UTHR fit in the risk graph?
|Annual EPS Est:||$8.92|
|Quarterly EPS Est:||3.27|